These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26125538)

  • 1. Armodafinil for fatigue associated with menopause: an open-label trial.
    Meyer F; Freeman MP; Petrillo L; Barsky M; Galvan T; Kim S; Cohen L; Joffe H
    Menopause; 2016 Feb; 23(2):209-14. PubMed ID: 26125538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial.
    Calabrese JR; Frye MA; Yang R; Ketter TA;
    J Clin Psychiatry; 2014 Oct; 75(10):1054-61. PubMed ID: 25099397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.
    Page BR; Shaw EG; Lu L; Bryant D; Grisell D; Lesser GJ; Monitto DC; Naughton MJ; Rapp SR; Savona SR; Shah S; Case D; Chan MD
    Neuro Oncol; 2015 Oct; 17(10):1393-401. PubMed ID: 25972454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study.
    Ketter TA; Amchin J; Frye MA; Gross N
    J Affect Disord; 2016 Jun; 197():51-7. PubMed ID: 26970266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of shift duration on the efficacy and tolerability of armodafinil in patients with excessive sleepiness associated with shift work disorder.
    Harsh J; Yang R; Hull SG
    Curr Med Res Opin; 2014 May; 30(5):945-51. PubMed ID: 24450538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
    Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.
    Lee EQ; Muzikansky A; Drappatz J; Kesari S; Wong ET; Fadul CE; Reardon DA; Norden AD; Nayak L; Rinne ML; Alexander BM; Arvold ND; Doherty L; Stefanik J; LaFrankie D; Ruland SF; Pulverenti J; Smith KH; Gaffey SC; Hammond S; Wen PY
    Neuro Oncol; 2016 Jun; 18(6):849-54. PubMed ID: 26902850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of soy lecithin on fatigue and menopausal symptoms in middle-aged women: a randomized, double-blind, placebo-controlled study.
    Hirose A; Terauchi M; Osaka Y; Akiyoshi M; Kato K; Miyasaka N
    Nutr J; 2018 Jan; 17(1):4. PubMed ID: 29310653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension.
    Menn SJ; Yang R; Lankford A
    J Clin Sleep Med; 2014 Nov; 10(11):1181-91. PubMed ID: 25325609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of wakefulness with lisdexamfetamine dimesylate, compared with placebo and armodafinil in healthy adult males undergoing acute sleep loss.
    Gasior M; Freeman J; Zammit G; Donnelly P; Gao J; Ferreira-Cornwell MC; Roth T
    J Clin Psychopharmacol; 2014 Dec; 34(6):690-6. PubMed ID: 25159886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.
    Bruce J; Hancock L; Roberg B; Brown A; Henkelman E; Lynch S
    Cogn Behav Neurol; 2012 Sep; 25(3):107-14. PubMed ID: 22960434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
    Lower EE; Malhotra A; Surdulescu V; Baughman RP
    J Pain Symptom Manage; 2013 Feb; 45(2):159-69. PubMed ID: 22917711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of armodafinil on objective sleepiness and performance in a shift work disorder sample unselected for objective sleepiness.
    Howard R; Roth T; Drake CL
    J Clin Psychopharmacol; 2014 Jun; 34(3):369-73. PubMed ID: 24717254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition.
    Freeman MP; Hirschberg AM; Wang B; Petrillo LF; Connors S; Regan S; Joffe H; Cohen LS
    Maturitas; 2013 Jun; 75(2):170-4. PubMed ID: 23602542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.
    Bivard A; Lillicrap T; Krishnamurthy V; Holliday E; Attia J; Pagram H; Nilsson M; Parsons M; Levi CR
    Stroke; 2017 May; 48(5):1293-1298. PubMed ID: 28404841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial.
    Peoples AR; Garland SN; Perlis ML; Savard J; Heckler CE; Kamen CS; Ryan JL; Mustian KM; Janelsins MC; Peppone LJ; Morrow GR; Roscoe JA
    J Cancer Surviv; 2017 Jun; 11(3):401-409. PubMed ID: 28105576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma.
    Berenson JR; Yellin O; Shamasunder HK; Chen CS; Charu V; Woliver TB; Sanani S; Schlutz M; Nassir Y; Swift RA; Andreu-Vieyra C; Vescio R
    Support Care Cancer; 2015 Jun; 23(6):1503-12. PubMed ID: 25370889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.